AngioDynamics (ANGO)
14.34
0.00 (0.00%)
Upcoming Events
Latest Headlines
AngioDynamics to Participate in Upcoming Investor Conferences
July 28, 2026 8:30 AM - BizWire
Form 4 ANGIODYNAMICS INC For: Jul 22 Filed by: Nighan Warren JR
July 24, 2026 6:11 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 22 Filed by: Piccinini Laura
July 24, 2026 6:11 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 22 Filed by: Clemmer James C
July 24, 2026 6:11 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 22 Filed by: Campbell Chad Thomas
July 24, 2026 6:11 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 22 Filed by: Trowbridge Stephen A
July 24, 2026 6:11 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: JOHNSON WESLEY
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Licitra Karen A
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: REED JAN STERN
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Nighan Warren JR
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Auen Eileen O'Shea
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Burgess Lorinda
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Tarnoff Michael E
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: DONNELLY HOWARD W
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Weiss Lawrence T
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Trowbridge Stephen A
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Campbell Chad Thomas
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 15 Filed by: Piccinini Laura
July 22, 2026 8:06 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Weiss Lawrence T
July 21, 2026 8:37 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Trowbridge Stephen A
July 21, 2026 8:32 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Piccinini Laura
July 21, 2026 8:28 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Nighan Warren JR
July 21, 2026 8:21 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Clemmer James C
July 21, 2026 8:17 PM - SEC Filing
Form 4 ANGIODYNAMICS INC For: Jul 16 Filed by: Campbell Chad Thomas
July 21, 2026 8:11 PM - SEC Filing
AngioDynamics (ANGO) PT Raised to $19 at H.C. Wainwright
July 16, 2026 6:51 AM - StreetInsider
AngioDynamics (ANGO) PT Raised to $17 at Freedom Broker
July 15, 2026 9:48 AM - StreetInsider
Form 10-K ANGIODYNAMICS INC For: May 31
July 14, 2026 3:43 PM - SEC Filing
AngioDynamics (ANGO) PT Raised to $20 at Canaccord
July 14, 2026 1:27 PM - StreetInsider
Form 8-K ANGIODYNAMICS INC For: Jul 14
July 14, 2026 7:31 AM - SEC Filing
AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
July 14, 2026 6:04 AM - StreetInsider
AngioDynamics reports fiscal 2026 full-year net sales of $320M
July 14, 2026 6:01 AM - StreetInsider
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
July 14, 2026 6:00 AM - BizWire
AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026
June 30, 2026 8:00 AM - BizWire
AngioDynamics gets FDA approval to study NanoKnife for BPH treatment
June 17, 2026 8:32 AM - StreetInsider
AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)
June 17, 2026 8:30 AM - BizWire
AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect
May 28, 2026 1:25 PM - BizWire
AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
May 27, 2026 8:30 AM - BizWire
Form SCHEDULE 13G/A ANGIODYNAMICS INC Filed by: Point72 Asset Management, L.P.
May 15, 2026 4:20 PM - SEC Filing
AngioDynamics reports sustained prostate cancer treatment outcomes at 24 months
May 13, 2026 9:00 AM - StreetInsider
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
May 13, 2026 9:00 AM - BizWire
Full Article List
